Passions

Modern literature 

Downhill skiing 

Distance running

Sabermetric baseball analysis

Admissions and credentials

Massachusetts

Experience

Hummingbird Bioscience Announces Exclusive Worldwide License Agreement With Callio Therapeutics

March 3, 2025

Cooley advised Hummingbird Bioscience, a Singapore-based biotherapeutics company working at the interface of artificial intelligence and human innovation to discover and develop transformative medicines for hard-to-treat diseases, on its exclusive worldwide license agreement with Callio Therapeutics, a newly launched biotech company focused on realizing the promise of multipayload antibody-drug conjugates (ADCs) to improve cancer therapy.

Read more

Related contacts

James Schneider
Partner, Boston
Jeffrey J. Tolin
Partner, New York
Steven Holm
Counsel, Singapore
Michael Fernando
Associate, London
Michael Bergmann
Partner, Washington, DC
Paula Holland
Partner, London
Nicola Squire
Partner, London
Yi Jia Ng
Special Counsel, Singapore
Bethan Chalmers
Associate, London
Amanda Pacheco
Associate, Palo Alto
Alexandra Paterson
Associate, London
Mara Rosario
Associate, Boston
Arda Can Tekin
Associate, London

Related Practices & Industries

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.